Your search returned 22 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 26941982
Year: 2016
Citation:
  • Journal of Gastrointestinal Oncology. 7(1):29-44, 2016 Feb
Institution:
  • Washington Cancer Institute.
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
2.
Paclitaxel is the pharmacologic near perfect chemotherapy for peritoneal metastases. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970160
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S240-S241, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
3.
Single institution best recommendation is HIPEC with cisplatin and docetaxel. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970157
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S79, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
4.
Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage. MedStar authors:
  • Gaur Khaitan, Puja
PMID:
  • 34012637
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(2):433-445, 2021 Apr.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/Thoracic Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Chen G, Deng C, Huang S, Khaitan PG, Koyanagi K, Liu H, Ozawa S, Piessen G, Qiao G, Shi R, Tian D, Wu H, Wu Y, Zhou Z, Zhuang W
DOI:
Add to cart
5.
Genetic targets for cancer control are a reality. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970166
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S204-S205, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
6.
PIPAC may work but more data is needed. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970164
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S271-S272, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
7.
Aggressive local treatments may prolong survival but do not have curative intent. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970158
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S68-S69, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
8.
Knowledgeable case selection results in favorable outcomes. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970169
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S30-S31, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
9.
Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970163
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S189-S190, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
10.
Adjuvant HIPEC for gastric cancer. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970159
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S18-S19, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
11.
The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970156
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S129-S130, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
12.
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33968440
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S231-S239, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH
DOI:
Add to cart
13.
A model for accurate histopathologic assessment refines treatment options. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970168
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S230, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
14.
Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970162
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S57-S58, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
15.
Current data is sufficient to recommend a current standard of care. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970154
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S45-S46, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
16.
Intraperitoneal chemotherapy for peritoneal metastases: confronting diversity, maximizing benefit. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33968421
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S1-S4, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
17.
High albumin-bilirubin grade predicts worse short-term complications in gastric cancer patients with metabolic syndrome: a retrospective study. MedStar authors:
  • Madan, Ankit
PMID:
  • 37969839
Year: 2023
Citation:
  • Journal of Gastrointestinal Oncology. 14(5):2039-2047, 2023 Oct 31.
Department:
  • Medstar Southern Maryland Hospital Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Luo X, Chen XD, Chen JL, Wang WB, Madan A, Song HN, Huang DD, Chen XL, Dong QT
DOI:
Add to cart
18.
Systemic therapy for advanced hepatocellular carcinoma: an update. [Review] MedStar authors:
  • Desai, Jasmin Radhika
PMID:
  • 28480064
Year: 2017
Citation:
  • Journal of Gastrointestinal Oncology. 8(2):243-255, 2017 Apr
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Desai JR, He AR, Ochoa S, Prins PA
DOI:
Add to cart
19.
Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970167
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S118-S119, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
20.
Cashin and Graf: long-term intraperitoneal 5-fluorouracil is superior to adjuvant FOLFOX in a randomized trial. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970155
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S136, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
21.
The options are neoadjuvant, adjuvant, or no chemotherapy at all: further data is needed. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33970152
Year: 2021
Citation:
  • Journal of Gastrointestinal Oncology. 12(Suppl 1):S214-S215, 2021 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
22.
Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. MedStar authors:
  • Stuart, O Anthony
  • Sugarbaker, Paul H
PMID:
  • 21160813
Year: 2010
Citation:
  • World Journal of Gastrointestinal Oncology. 2(1):19-30, 2010 Jan 15.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Stuart OA, Sugarbaker PH, Van der Speeten K
DOI:
Add to cart
Pages

Powered by Koha